Skip to main content
. 2019 Nov 21;19:196. doi: 10.1186/s12876-019-1110-1

Fig. 6.

Fig. 6

Clinical remission and response rates of the GMA therapy in the five major special situation sub-groups of patients with UC. UC ulcerative colitis, GMA granulocyte and monocyte adsorptive apheresis